Ongoing
Closed
Pharmacogenomics for predicting liver toxicity in multiple sclerosis patients treated with interferon beta
Mon Jan 1, 2018
Mindfulness INnovative Device-assisted For Multiple Sclerosis patients (MIND4MS)
Fri 1th Sep 2017. p.m. CEST
A Prospective, Non-Interventional, Observational, Multicenter Study to Investigate Dosage, Effectiveness, and Safety of Perampanel when Used as First Adjunctive Therapy in the Routine Clinical Care of Subjects ≥12 Years with Partial Onset Seizures With or Without Secondary Generalization or with Primary Generalized Tonic–Clonic Seizures Associated with Idiopathic Generalized Epilepsy. Study E2007-M044-512
Fri 1th Sep 2017. p.m. CEST
